.....so ... what's your point ? This was the last decent blockbuster indication partnership deal Mesoblast did and yes it did have a premium attached for the buy in, which was exactly my point and why I posted the information
You don't think SI will command a premium 14 years later with the completion of the phase 3 DREAM-HF trial; the LVAD trial: the HLHS results; the FDA willingness to consider an AA pathway for CHF and of course all of the additional data we have ?
I believe a CHF partnership now will dwarf any previous Mesoblast partnerships but hey that's just my opinion.
.....so ... what's your point ? This was the last decent...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.020(1.91%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.07 | $1.04 | $4.010M | 3.797M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 67587 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 45960 | 7 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.07 |
Change
0.020 ( 2.55 %) |
||||
| Open | High | Low | Volume | ||
| $1.04 | $1.07 | $1.04 | 699949 | ||
| Last updated 15.59pm 14/05/2024 ? | |||||
| MSB (ASX) Chart |